Bone Marrow Transplantation and Cataract Development

Archives of Ophthalmology

Volumn 111, Issue 10, 1993, Pages 1367-1373

  Dunn, James P ^a   Jabs, Douglas A ^a   Wingard, John ^c,d   Enger, Cheryl ^a   Vogelsang, Georgia ^b   Santos, George ^b  

^a Departments of Ophthalmology   (United States)

^b Departments of Oncology   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; THALIDOMIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CATARACT; CATARACT EXTRACTION; CATARACTOGENESIS; CHILD; CORTICOSTEROID THERAPY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISUAL ACUITY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CATARACT; CATARACT EXTRACTION; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HUMAN; INFANT; MALE; MIDDLE AGE; RETROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; WHOLE-BODY IRRADIATION;

EID: 0027431488     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1993.01090100075031     Document Type: Article

References (37)

1. 1. Elfenbein GJ, Mellits ED, Santos GW. Patients with aplastic anemia: engraftment and survival after allogeneic bone marrow transplantation for severe aplastic anemia. Transplant Proc. 1983;15:1412-1416.
2. 2. Wingard JR, Piantadosi S, Santos GW, et al. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. J Clin Oncol. 1990;8:820-830.
3. 3. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983;309:1347-1353.
4. 4. Champlin RE, Gale RP. The early complications of bone marrow transplantation. Semin Hematol. 1984;21:101-108.
5. 5. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versushost disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
6. 6. Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: beneficial effect of a protective environment N Engl J Med. 1983;308:302-307.
7. 7. Parkman R. Graft-versus-host disease. Ann Rev Med. 1991;42:189-197.
8. 8. Sullivan KM, Deeg HJ, Sanders JE, et al. Late complications after marrow transplantation. Semin Hematol. 1984;21:53-63.
9. 9. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267-276.
10. 10. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation, I: clinical study. Arch Ophthalmol. 1983;101:580-584.
11. 11. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation, Ill: conjunctival graft-versus-host disease. Arch Ophthalmol. 1989;107:1343-1348.
12. 12. Lappi M, Rajantie J, Uusitalo RJ. Irradiation cataract in children after bone marrow transplantation. Graefes Arch Clin Exp Ophthalmol. 1990;228:218-221.
13. 13. Deeg HJ, Flournoy N, Sullivan KM, et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys. 1984;10:957-964.
14. 14. Calissendorff B, Bolme P, el Azazi M. The development of cataract in children as a late side-effect of bone marrow transplantation. Bone Marrow Transplant. 1991;7:427-429.
15. 15. Bender-Gotze C. Late effects of allogeneic bone marrow transplantation. Pediatrician. 1991;18:71-75.
16. 16. Hoover DL, Smith LEH, Turner SJ, Gelber RD, Sallan SE. Ophthalmic evaluation of survivors of acute lymphoblastic leukemia. Ophthalmology. 1988;95:151-155.
17. 17. Bray LC, Carey PJ, Proctor SJ, Evans RGB. Hamilton PJ. Ocular complications of bone marrow transplantation. Br J Ophthalmol. 1991;75:611-614.
18. 18. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host disease in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204.
19. 19. Vogelsang GB, Farmer ER, Hess AD, et al. Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med. 1992;326:1055-1058.
20. 20. Kaplan EM, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1959;53:457.
21. 21. Black RL, Oglesby RB, von Sallmann L, Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA. 1960:174:166-171.
22. 22. Oglesby RB, Black RL, von Sallmann L, Bunim JJ. Cataracts in rheumatoid arthritis patients treated with corticosteroids: description and differential diagnosis. Arch Ophthalmol. 1961;66:519-523.
23. 23. Oglesby RB, Black RL, von Sallmann L, Bunim JJ. Cataracts in patients with rheumatic diseases treated with corticosteroids: further observations. Arch Ophthalmol. 1961;66:625-630.
24. 24. Kirkman RL, Strom TB, Weir MR, Tilney NL. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation. 1982;34:347-351.
25. 25. Urban RC Jr, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986;31:102-110.
26. 26. Sonneveld P, Peperkamp E, van Kekkum DW. Incidence of cataracts in rhesus monkeys treated with whole-body irradiation. Radiology. 1979;133:227-229.
27. 27. von Sallmann L. The lens epithelium in the pathogenesis of cataract. Am J Ophthalmol. 1957;44:159-170.
28. 28. Down JD, Berman AJ, Warhol M, et al. Late tissue-specific toxicity of total body irradiation and busulfan in a murine marrow transplant model. Int J Radiat Oncol Biol Phys. 1989;17:109-116.
29. 29. Merriam GR Jr, Focht EF. A clinical study of radiation cataracts and the relationship to dose. Am J Roentgenol Radium Ther Nucl Med. 1957;77:759-785.
30. 30. Weaver RG, Chauvenet AR, Smith TJ, Schwartz AC. Ophthalmic evaluation of long-term survivors of childhood: acute lymphoblastic leukemia. Cancer. 1986;58:963-968.
31. 31. Vizel M. Oster MW. Ocular side effects of cancer chemotherapy. Cancer. 1982;49:1999-2002.
32. 32. Podos SM, Canellos GP. Lens changes in chronic granulocytic leukemia: possible relationship to chemotherapy. Am J Ophthalmol. 1969;68:500-504.
33. 33. Fraunfelder FT, Meyer SM. Ocular toxicity of antineoplastic agents. Ophthalmology. 1983;90:1-3.
34. 34. Spaeth GL, von Sallman L. Corticosteroids and cataracts. Int Ophthalmol Clin. 1966;6:915-929.
35. 35. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population: the Beaver Dam eye study. Ophthalmology. 1992;99:546-552.
36. 36. Crews SJ. Posterior subcapsular lens opacities in patients on long-term corticosteroid therapy. Br J Med. 1963;1:1644-1647.
37. 37. Loredo A, Rodriguez RS, Murillo L. Cataracts after short-term corticosteroid treatment. N Engl J Med. 1972;286:160.